Maze Therapeutics Inc (MAZE:NASDAQ)

$44.83 -0.47 (-1.04%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 87

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Maze Therapeutics Inc (MAZE:NASDAQ) News Sources

Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Apellis Pharmaceuticals (APLS)

The Globe and Mail

external link

Chronic Kidney Disease Market Competitive Landscape Report 2026: Comprehensive Insights About 75+ Companies and 95+ Drugs by Product Type, Stage, Route of Administration, and ...

Yahoo Finance UK

external link
MAZE stock
MAZE stock price
MAZE stock price today
MAZE stock prediction
MAZE earnings date
MAZE news
MAZE price
MAZE share
MAZE share price
MAZE shares
MAZE ceo
MAZE premarket
$MAZE
MAZE ticker
MAZE after hours
MAZE stock
MAZE stock price
MAZE stock price today
MAZE stock prediction
MAZE earnings date
MAZE news
MAZE price
MAZE share
MAZE share price
MAZE shares
MAZE ceo
MAZE premarket
$MAZE
MAZE ticker
MAZE after hours

Maze Therapeutics Inc (MAZE:NASDAQ) FAQs

toggle

What is the current price of Maze Therapeutics Inc (MAZE:NASDAQ)?

The current price of Maze Therapeutics Inc (MAZE:NASDAQ) is $44.83.


toggle

Maze Therapeutics Inc (MAZE:NASDAQ) absolute price change since previous trading day?

The absolute price change of Maze Therapeutics Inc (MAZE:NASDAQ) since the previous trading day is $-0.47.


toggle

Maze Therapeutics Inc (MAZE:NASDAQ) percentage price change since previous trading day?

The percentage price change of Maze Therapeutics Inc (MAZE:NASDAQ) since the previous trading day is -1.04%.


toggle

What is This Week's average sentiment score for Maze Therapeutics Inc (MAZE:NASDAQ)?

This Week's average sentiment score for Maze Therapeutics Inc (MAZE:NASDAQ) is 87 out of 100.


toggle

What is This Week's average sentiment for Maze Therapeutics Inc (MAZE:NASDAQ)?

This Week's sentiment for Maze Therapeutics Inc (MAZE:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.